Socio-Economics History Blog

Socio-Economics & History Commentary

High-Dose Vitamin C Injections Shown To Annihilate Cancer Cells

Cancer and Vitamin C explains, in plain language, the nature and known causes of cancer, covering nearly all its different forms and their natural progression. It also weighs the value and limitations of various modes of treatment: surgery, radiation, chemotherapy, hormones, immunotherapy, and a number of unorthodox ones. The value of vitamin C as an adjunct therapy is corroborated by detailed accounts of cancer patients who have derived varying degrees of benefit from vitamin C treatment. –Midwest Book Review
About the Author
LINUS PAULING, Ph.D., won the Nobel Prize for Chemistry in 1954 and for Peace in 1962. EWAN CAMERON, M.B., Ch.B., F.R.C.S. (Edinburgh and Glasgow), was Medical Director of the Linus Pauling Institute of Science and Medicine.

  • High-Dose Vitamin C Injections Shown To Annihilate Cancer Cells
    by ,  
    High dose vitamin C injections have shown positive results in fighting cancer cells in studies done in vitro, on mice and on humans. Peer-reviewed medical research has been recently published in the journal Science Translational Medicine that reports the findings of a team of researchers from the University of Kansas who tested the effects of vitamin C given in high doses intravenously on a group of human subjects with cancer. They found that the injections fought cancer cells yet left healthy cells well intact unlike chemotherapy.

    The BBC reports that vitamin C effectively targeted ovarian cancer cells while completely avoiding healthy cells. The benefits of high-dose vitamin C injections were also observed in conjunction with chemotherapy. Some are suggesting that the injections provide a great boost alongside chemo treatment. However chemo does destroy all cells, both healthy and not and is often the cause of death for cancer patients.

    Research on high dose vitamin C injections began in the 1970s when Linus Pauling, a chemist from Oregon State University began his research. New research involved injecting high doses of vitamin C intravenously into human ovarian cells. The tests were conducted in vitro, on mice and in 22 humans subjects.

    “Patients are looking for safe and low-cost choices in their management of cancer… Intravenous vitamin C has that potential based on our basic science research and early clinical data.” Dr. Jeanne Drisko, a co-author of the study.

    Researchers admit more research is unlikely because drug companies cannot patent vitamins.

    Generally the next step in this type of research would be creating human clinical trials that are much larger. Regardless of the fact this study is quite convincing, larger and more widespread testing would need to be done. But these types of trials cost a great deal of money. While clinical trials are often funded by large drug companies when testing out new medications, the researchers involved in this study feel drug companies won’t fund such research because they can’t patent the natural substance that is vitamin C. Allowing research like this could potentially destroy the multi-billion dollar cancer industry.

    read more.

Click on image for article.


August 12, 2016 - Posted by | Medicine & Health |

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: